BELEAVE INC. Inactive Instrument
Beleave Inc. Share Price Canadian Securities Exchange
Equities
BE
CA0775611084
Pharmaceuticals
| Sales 2018 | - | Sales 2019 | 2.37 3.25 190.05 | Capitalization | 30.37M 41.51M 2.43B |
|---|---|---|---|---|---|
| Net income 2018 | -12M -16.4M -961M | Net income 2019 | -33M -45.11M -2.64B | EV / Sales 2018 | - |
| Net cash position 2018 | 5.2M 7.11M 416M | Net Debt 2019 | 10.32M 14.1M 826M | EV / Sales 2019 | 17,137,012 x |
| P/E ratio 2018 |
-4.72
x | P/E ratio 2019 |
-0.76
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 98.39% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | - | 25/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 14/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 23/10/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 14/12/15 |
| Founder | - | 25/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 23/10/18 |
Beleave Inc. is a Canada-based cannabis company. Through its wholly owned subsidiary, Beleave Kannabis Corp, the Company is a license holder and producer of cannabis, which includes cultivation, processing, medical sales and research. Its segment includes Cannabis Products and Patient Network. Its Cannabis Products segment is a licensed producer of marihuana for medical purposes. Its Patient Network segment is a patient network of medical cannabis services. It cultivates cannabis flower, oil and extracts for medical and recreational markets. Its product line includes cannabis-infused products, oils and vape pens. The Company operates a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| +0.09% | 1.65B | |
| -7.89% | 1.68B | |
| -12.97% | 1.53B | |
| +33.40% | 1.38B |
